Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology

dc.contributor.authorSalman, Andaç
dc.contributor.authorAlper, Sibel
dc.contributor.authorAtakan, Nilgün
dc.contributor.authorBorlu, Murat
dc.contributor.authorCanpolat, Filiz
dc.contributor.authorErdem, Teoman
dc.contributor.authorErdem, Yasemin
dc.contributor.authorGül, Ülker
dc.contributor.authorKartal, Selda Pelin
dc.contributor.authorKoca, Rafet
dc.contributor.authorKüçük, Özlem Su
dc.contributor.buuauthorBaşkan, Emel Bülbül
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-0144-3263tr_TR
dc.contributor.researcheridAAH-1388-2021tr_TR
dc.contributor.scopusid6602518817tr_TR
dc.date.accessioned2023-11-02T10:42:30Z
dc.date.available2023-11-02T10:42:30Z
dc.date.issued2020-12
dc.identifier.citationSalman, A. vd. (2020). "Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology". Turkderm Turkish Archives of Dermatology and Venereology, 54(2), 71-75.tr_TR
dc.identifier.endpage75tr_TR
dc.identifier.issn2717-6398
dc.identifier.issn2651-5164
dc.identifier.issue2tr_TR
dc.identifier.scopus2-s2.0-85089913448tr_TR
dc.identifier.startpage71tr_TR
dc.identifier.urihttps://doi.org/10.4274/turkderm.galenos.2020.80000
dc.identifier.urihttps://jag.journalagent.com/turkderm/pdfs/TURKDERM_54_2_71_75.pdf
dc.identifier.urihttp://hdl.handle.net/11452/34757
dc.identifier.volume54tr_TR
dc.identifier.wos000544409600008tr_TR
dc.indexed.scopusScopusen_US
dc.indexed.trdizinTrDizintr_TR
dc.indexed.wosESCIen_US
dc.language.isoenen_US
dc.publisherGalenos Yayıncılıktr_TR
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalTurkderm Turkish Archives of Dermatology and Venereologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDermatologyen_US
dc.subjectAtopic dermatitisen_US
dc.subjectCovid-19en_US
dc.subjectTreatmenten_US
dc.subjectUrticariaen_US
dc.subjectOmalizumaben_US
dc.subjectMetaanalysisen_US
dc.subjectAtopik dermatittr_TR
dc.subjectCOVID-19tr_TR
dc.subjectDupilumabtr_TR
dc.subjectTedavitr_TR
dc.subjectÜrtikertr_TR
dc.subject.emtreeAzathioprineen_US
dc.subject.emtreeCyclosporineen_US
dc.subject.emtreeDupilumaben_US
dc.subject.emtreeInterleukin 1betaen_US
dc.subject.emtreeInterleukin 6en_US
dc.subject.emtreeMethotrexateen_US
dc.subject.emtreeMycophenolate mofetilen_US
dc.subject.emtreeOmalizumaben_US
dc.subject.emtreePrednisoloneen_US
dc.subject.emtreeAtopic dermatitisen_US
dc.subject.emtreeCoronavirus disease 2019en_US
dc.subject.emtreeCytokine stormen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHypertensionen_US
dc.subject.emtreeImmunosuppressive treatmenten_US
dc.subject.emtreeImmunotherapyen_US
dc.subject.emtreeInflammationen_US
dc.subject.emtreeLetteren_US
dc.subject.emtreeObesityen_US
dc.subject.emtreePandemicen_US
dc.subject.emtreeRandomized controlled trial (topic)en_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeSevere acute respiratory syndrome coronavirus 2en_US
dc.subject.emtreeShared decision makingen_US
dc.subject.emtreeSystemic therapyen_US
dc.subject.emtreeUrticariaen_US
dc.subject.scopusSkin; Allergic contact dermatitis; COVID-19en_US
dc.subject.wosDermatologyen_US
dc.titleRecommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatologyen_US
dc.title.alternativeCOVID-19 pandemisi süresince ürtiker ve atopik dermatitte sistemik tedavilerin kullanımına ilişkin öneriler: Türk Dermatoloji Derneği dermatoallerji çalışma grubu bildirisitr_TR
dc.typeLetter
dc.wos.quartileQ4en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Başkan_vd_2020.pdf
Size:
151.57 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: